Avantax Advisory Services’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $662K | Sell |
7,263
-262
| -3% | -$23.9K | ﹤0.01% | 1417 |
|
2025
Q1 | $852K | Buy |
7,525
+693
| +10% | +$78.4K | 0.01% | 1179 |
|
2024
Q4 | $722K | Buy |
6,832
+1,833
| +37% | +$194K | ﹤0.01% | 1223 |
|
2024
Q3 | $540K | Buy |
4,999
+719
| +17% | +$77.6K | ﹤0.01% | 1359 |
|
2024
Q2 | $464K | Buy |
4,280
+867
| +25% | +$94.1K | ﹤0.01% | 1411 |
|
2024
Q1 | $450K | Sell |
3,413
-34
| -1% | -$4.49K | ﹤0.01% | 1095 |
|
2023
Q4 | $420K | Sell |
3,447
-493
| -13% | -$60K | ﹤0.01% | 1071 |
|
2023
Q3 | $442K | Buy |
3,940
+363
| +10% | +$40.7K | ﹤0.01% | 995 |
|
2023
Q2 | $521K | Sell |
3,577
-85
| -2% | -$12.4K | 0.01% | 929 |
|
2023
Q1 | $473K | Buy |
3,662
+24
| +0.7% | +$3.1K | 0.01% | 940 |
|
2022
Q4 | $464K | Sell |
3,638
-729
| -17% | -$92.9K | 0.01% | 898 |
|
2022
Q3 | $457K | Buy |
4,367
+902
| +26% | +$94.4K | 0.01% | 818 |
|
2022
Q2 | $364K | Buy |
3,465
+470
| +16% | +$49.4K | 0.01% | 923 |
|
2022
Q1 | $381K | Buy |
2,995
+1,162
| +63% | +$148K | 0.01% | 893 |
|
2021
Q4 | $226K | Buy |
+1,833
| New | +$226K | ﹤0.01% | 1115 |
|
2020
Q4 | – | Sell |
-3,870
| Closed | -$513K | – | 1374 |
|
2020
Q3 | $513K | Buy |
+3,870
| New | +$513K | 0.01% | 775 |
|
2020
Q1 | – | Sell |
-1,406
| Closed | -$205K | – | 907 |
|
2019
Q4 | $205K | Buy |
+1,406
| New | +$205K | ﹤0.01% | 775 |
|